Web14 Jul 2024 · IFR=infection fatality risk. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. * Of whom approximately 4065 (4·9%) live in assisted care facilities. Of … WebORIGINAL ARTICLE Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study Pierre-Olivier Bridevaux,1 J-D Aubert,2 P M Soccal,1,3 J …
Investigating survivorship bias: The case of the 1918 flu pandemic
Web5 Jan 2024 · Laurent Kaiser graduated from the University of Geneva in 1987 and is a certified specialist in infectious diseases, internal medicine and clinical microbiology. He … WebEarly treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Michael G Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, Melissa Mitchener, Kenji Tsuchiya, Takeki Uehara, Frederick G Hayden. covanta europe assets
Influenza virus neuraminidase inhibitors - The Lancet
WebLaurent Kaiser; Objective To longitudinally evaluate the persistence of humoral immunity up to six months in a cohort of hospital employees with mild COVID-19. Methods We … WebLaurent Kaiser d Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland;g Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland;h Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, SwitzerlandView further author information Web26 Aug 2024 · Laurent Kaiser contributed to the conceptualization, supervision, and writing and editing of the review. We thank Florian Laubscher and Patrick Lane of ScEYEnce … covanta essex